Clinical Trial

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Study acronym: PEER
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study will examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.
Protocol Amendment History 20 amendments
This ClinicalTrials.gov record has been amended 20 times since 2007-12-05; most recent amendment 2025-09-14.
Status change: Recruiting → Active, Not Recruiting 2025-09-14
Trial Details
NCT Number NCT00568997
Lead Sponsor Bausch Health Americas, Inc.
Collaborators: Clinical Research Computing Unit (University of Pennsylvania)
Conditions Atopic Dermatitis
Enrollment 8,000 participants
Start Date 2005-06-27
Primary Completion 2027-12 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2025-09-16